SoftOx Solutions AS 

€0
10
-€0.01-60% Thursday 07:18

Statistics

Day High
0
Day Low
0
52W High
0.05
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
9.02M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

25MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-19,388.24%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
37,994.87Revenue
-7.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6FV.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap322.3B
Roche Holding AG is a major player in the healthcare sector, competing in the development of medical solutions, including those for infection prevention which is a key area for SoftOx.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson offers a wide range of healthcare products, including antiseptics and wound care solutions that directly compete with SoftOx's product offerings.
Pfizer
PFE
Mkt Cap153.13B
Pfizer Inc. is involved in the development and manufacturing of healthcare products, including those for infection control, making it a competitor in the same space as SoftOx.
Abbott Laboratories
ABT
Mkt Cap174.29B
Abbott Laboratories operates in various healthcare segments, including diagnostics and medical devices that can be used in infection control, competing with SoftOx Solutions.
Becton Dickinson
BDX
Mkt Cap55.87B
Becton, Dickinson and Company specializes in medical devices, including infection prevention technologies, making it a competitor to SoftOx Solutions.
3M
MMM
Mkt Cap79.17B
3M Company has a significant presence in the healthcare sector, including infection prevention solutions and medical supplies that compete with SoftOx's offerings.
Gilead Sciences
GILD
Mkt Cap172.51B
Gilead Sciences, Inc. is known for its antiviral drugs, which can be seen as indirect competitors to SoftOx's infection prevention technologies.
Merck
MRK
Mkt Cap300.2B
Merck & Co., Inc. is a global healthcare company that offers vaccines and health solutions, including those for infection prevention, competing with SoftOx.
AMGEN
AMGN
Mkt Cap189.22B
Amgen Inc. focuses on human therapeutics, including treatments that could compete with SoftOx's solutions in the healthcare market.
Stryker
SYK
Mkt Cap129.89B
Stryker Corporation specializes in medical technologies, including surgical and infection prevention products, making it a competitor to SoftOx Solutions.

About

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. SoftOx Solutions AS was founded in 2012 and is headquartered in Fornebu, Norway.
Show more...
CEO
Mr. Ulrik Spork
Employees
2
Country
Other
ISIN
NO0010811961
WKN
000A2JNDN

Listings

0 Comments

Share your thoughts

FAQ

What is SoftOx Solutions AS stock price today?
The current price of 6FV.F is €0 EUR — it has decreased by -60% in the past 24 hours. Watch SoftOx Solutions AS stock price performance more closely on the chart.
What is SoftOx Solutions AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange SoftOx Solutions AS stocks are traded under the ticker 6FV.F.
Is SoftOx Solutions AS stock price growing?
6FV.F stock has risen by +0% compared to the previous week, the month change is a -20% fall, over the last year SoftOx Solutions AS has showed a -33.33% decrease.
What is SoftOx Solutions AS market cap?
Today SoftOx Solutions AS has the market capitalization of 9.02M
What is SoftOx Solutions AS revenue for the last year?
SoftOx Solutions AS revenue for the last year amounts to 37,994.87 EUR.
What is SoftOx Solutions AS net income for the last year?
6FV.F net income for the last year is -7.37M EUR.
How many employees does SoftOx Solutions AS have?
As of April 15, 2026, the company has 2 employees.
In which sector is SoftOx Solutions AS located?
SoftOx Solutions AS operates in the Health & Wellness sector.
When did SoftOx Solutions AS complete a stock split?
The last stock split for SoftOx Solutions AS was on July 02, 2018 with a ratio of 50:1.
Where is SoftOx Solutions AS headquartered?
SoftOx Solutions AS is headquartered in Fornebu, Other.